Biomarker discovery would be an important tool in advancing and utilizing the concept of precision and personalized medicine in the clinic. Discovery of novel variants in local population provides confident targets for developing biomarkers for personalized medicine. We identified the need to generate high-quality sequencing data from local colorectal cancer patients and understand the pattern of occurrence of variants. In this report, we used archived samples from Saudi Arabia and used the AmpliSeq comprehensive cancer panel to identify novel somatic variants. We report a comprehensive analysis of next-generation sequencing results with a coverage of >300X. We identified 466 novel variants which were previously unreported in COSMIC and ICGC databases. We analyzed the genes associated with these variants in terms of their frequency of occurrence, probable pathogenicity, and clinicopathological features. Among pathogenic somatic variants, 174 were identified for the first time in the large intestine. APC, RET, and EGFR genes were most frequently mutated. A higher number of variants were identified in the left colon. Occurrence of variants in ERBB2 was significantly correlated with those of EGFR and ATR genes. Network analyses of the identified genes provide functional perspective of the identified genes and suggest affected pathways and probable biomarker candidates. This report lays the ground work for biomarker discovery and identification of driver gene mutations in local population.
6 December 2023 in The American Journal of Dermatopathology
NUT carcinoma (NC) is a rare and aggressive neoplasm associated with a poor prognosis. NC is characterized by a NUTM1-rearrangement on chromosome 15q14, commonly fused with the BRD4 or BRD3 gene. A rare subset of NC defined by fusion of NUTM1 with the MGA gene has been identified, showing mesenchymal differentiation on histology. Few cases of spindle cell sarcomas harboring MGA::NUTM1 gene fusions have been reported in the literature. We describe a case of spindle cell sarcoma harboring an MGA::NUTM1 fusion in a 6-year-old male patient. In contrast to typical cases of spindle cell carcinomas or NC, NUTM1 fusion-positive sarcomas are associated with a better prognosis. This report highlights the importance of diagnostic workup of undifferentiated neoplasms, as identification of the MGA::NUTM1 fusion in spindle cell sarcoma could be used in treatment algorithms and lead to better outcomes, to the benefit of patients.
Discovery of novel variants from data derived from local population provides confident targets for developing biomarkers for personalized medicine. Biomarker discovery would be an important tool in advancing and utilizing the concept of precision and personalized medicine in the clinic. We identified the need to generate high quality sequencing data from local population and understand the pattern of occurrence of variants in colorectal cancer patients. In this report, we used archived samples from Saudi Arabia and used Ampliseq Comprehensive Cancer panel to identify novel somatic variants. We report a comprehensive analysis of next generation sequencing results with a coverage of >300X. We identified 466 novel variants which were previously unreported in COSMIC and ICGC databases. We analyzed the genes associated with these variants in terms of their frequency of occurrence, probable pathogenicity and clinicopathological features. Among pathogenic somatic variants, 174 were identified for the first time in large intestine. APC, RET and EGFR genes were most frequently mutated. Higher number of variants were identified in left colon. Occurrence of variants in ERBB2 was significantly correlated with those of EGFR and ATR genes. Network analyses of the identified genes provide functional perspective of the identified genes and suggest affected pathways and probable biomarker candidates. This report lays the ground work for biomarker discovery and identification of driver gene mutations in local population.
3 January 2023 in Open Access Macedonian Journal of Medical Sciences
Giant cell tumor of soft tissue (GCTST) is a very rare neoplasm that occurs predominantly in in the fifth decade of life presented as a benign looking painless mass associated with a local recurrence rate of 12% and very rare metastasis. We report a case of this rare entity presented with unusual presentations in a young boy which was diagnosed by histopathological examination and immunohistochemistry after complete excision raising the awareness of diagnosis and management of this unusual entity.
30 June 2016 in Saudi Journal of Internal Medicine
Background: Primary extranodal non-Hodgkin's lymphoma is emerging as a common entity that presents with diverse clinical features, morphology and immunophenotyping patterns. Aim: The aim of this study is to analyze the clinicopathological and immunohistochemical features in patients with primary extranodal non-Hodgkin's lymphoma. Settings and Design: This is a retrospective observational study from pre-recorded hospital data. Materials and Methods: The data of all histologically confirmed patients with non-Hodgkin's lymphoma were retrieved to identify those confirmed as primary extranodal non-Hodgkin's lymphoma among patients attending King Abdulaziz University Hospital, Jeddah, Saudi Arabia over the last 12 years (January 2003 - May 2015). Retrieved data was analyzed with regards to the demography, clinical features, histopathological and immunohistochemical features. Lymphoma of the study group were classified according to World Health Organization classification of lymphomas 2008. Result: A total of 218 patients with histologically confirmed non-Hodgkin's lymphoma were identified. Seventy-nine (36.2%) had primary extranodal non-Hodgkin's lymphoma. The most common age group affected was 20-39 years for both genders. Gastrointestinal system was the most frequently involved system for both genders. Colon was the most common site involved among males, while thyroid and thymus were the most common sites involved among females. Diffuse large B cell lymphoma was the most common histological type. Conclusion: Primary extranodal non-Hodgkin's lymphoma is common in Saudi Arabia affecting males and females almost equally in the third and fourth decades of life, with diffuse large B cell lymphoma being the most common histologic subtype.
Giant cell tumor of bone (GCTB) is a locally aggressive tumor driven by neoplastic mononuclear stromal cells. Stromal immunophenotyping may support diagnosis in giant cell-rich mimics and provide insight into tumor biology. Archival formalin-fixed, paraffin-embedded tissue samples from 31 GCTB cases diagnosed between 2015 and 2025 were studied and reviewed by consultant pathologists on-site and remotely to confirm the diagnosis and assess stromal atypia and mitoses. Immunohistochemistry for p63, cluster of differentiation 10 (CD10), and Ki-67 was performed and interpreted in stromal cells only; p63 and CD10 expression were categorized as low or high, and Ki-67 labeling index (LI) was grouped using a 10% cutoff. Available clinical variables included age, sex, anatomical site, tumor size, and recurrent-case status. Recurrent-case status was based on documentation at presentation or referral, not on prospectively confirmed recurrence. The mean age was 42.5 ± 15.4 years; 16/31 cases (51.6%) were female. Recurrent-case status was recorded in 14/31 cases (45.2%). High p63 and CD10 expression were observed in 20/31 cases (64.5%) and 22/31 cases (71.0%), respectively. In univariate analysis, CD10-high expression was associated with recurrent-case status ( P = .021), while p63-high expression showed a borderline association ( P = .057). Ki-67 LI was not associated with recurrent-case status ( P = .389). p63 expression correlated significantly with CD10 expression ( P = .003) and with higher Ki-67 LI. Stromal p63 and CD10 were commonly expressed in GCTB. CD10-high expression was associated with recurrent-case status in univariate analysis, but this exploratory finding should not be interpreted as recurrence prediction.